Unglycosylated Soluble SARS-CoV-2 Receptor Binding Domain (RBD) Produced in E. coli Combined with the Army Liposomal Formulation Containing QS21 (ALFQ) Elicits Neutralizing Antibodies against Mismatched Variants
大肠杆菌中产生的非糖基化可溶性 SARS-CoV-2 受体结合域 (RBD) 与含有 QS21 (ALFQ) 的陆军脂质体制剂相结合，可引发针对错配变体的中和抗体
期刊:Vaccines
影响因子:
doi:10.3390/vaccines11010042
Arasu Balasubramaniyam, Emma Ryan, Dallas Brown, Therwa Hamza, William Harrison, Michael Gan, Rajeshwer S Sankhala, Wei-Hung Chen, Elizabeth J Martinez, Jaime L Jensen, Vincent Dussupt, Letzibeth Mendez-Rivera, Sandra Mayer, Jocelyn King, Nelson L Michael, Jason Regules, Shelly Krebs, Mangala Rao, G
